☆ 4.6 Article

Durable biochemical response and safety with oral octreotide capsules in acromegaly

EUROPEAN JOURNAL OF ENDOCRINOLOGY (2022)

Related references

Note: Only part of the references are listed.

Article Endocrinology & Metabolism

Maintenance of response to oral octreotide compared with injectable somatostatin receptor ligands in patients with acromegaly: a phase 3, multicentre, randomised controlled trial

Maria Fleseriu et al.

Summary: This study compared the efficacy and safety of oral octreotide capsules with injectable somatostatin receptor ligands in patients with acromegaly. The findings showed that oral octreotide capsules were non-inferior to injectable somatostatin receptor ligands in maintaining biochemical response. They may serve as a favorable alternative treatment for many patients with acromegaly.

LANCET DIABETES & ENDOCRINOLOGY (2022)

Add to Collection

Article Endocrinology & Metabolism

A Pituitary Society update to acromegaly management guidelines

Maria Fleseriu et al.

Summary: This article focuses on recent advances in the management of acromegaly, emphasizing how key developments affect treatment decisions and outcomes. It also explores the potential role of recently FDA-approved therapies and combination therapies in the treatment arsenal.

PITUITARY (2021)

Add to Collection

Article Endocrinology & Metabolism

COVID-19 and the pituitary

Stefano Frara et al.

Summary: COVID-19 has been shown to have endocrine manifestations, particularly affecting patients with pituitary dysfunctions. More research is needed to understand the impact of COVID-19 on pituitary diseases and to develop appropriate management strategies.

PITUITARY (2021)

Add to Collection

Article Endocrinology & Metabolism

Disease and Treatment-Related Burden in Patients With Acromegaly Who Are Biochemically Controlled on Injectable Somatostatin Receptor Ligands

Maria Fleseriu et al.

Summary: This study examined the burden associated with SRL injections in acromegaly patients who have achieved biochemical control. Despite being biochemically controlled, patients commonly reported experiencing symptoms that interfere with daily life and work, along with gastrointestinal side effects and injection site reactions. This highlights the significant disease burden that still persists for these patients.

FRONTIERS IN ENDOCRINOLOGY (2021)

Add to Collection

Article Endocrinology & Metabolism

Results from ACROCOVID: an international survey on the care of acromegaly during the COVID-19 era

Andrea Giustina et al.

Summary: The ongoing COVID-19 pandemic has significantly affected the care of acromegaly patients, prompting endocrinologists to adopt new methods of care in order to better prepare for the post-COVID-19 era.

ENDOCRINE (2021)

Add to Collection

Article Endocrinology & Metabolism

A Consensus on the Diagnosis and Treatment of Acromegaly Comorbidities: An Update

Andrea Giustina et al.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2020)

Add to Collection

Review Medicine, General & Internal

Pituitary-Tumor Endocrinopathies

Shlomo Melmed

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Add to Collection

Article Endocrinology & Metabolism

Patient reported outcome data from acromegaly patients treated with injectable somatostatin receptor ligands (SRLs) in routine clinical practice

Eliza B. Geer et al.

BMC ENDOCRINE DISORDERS (2020)

Add to Collection

Article Endocrinology & Metabolism

Maintenance of Acromegaly Control in Patients Switching From Injectable Somatostatin Receptor Ligands to Oral Octreotide

Susan L. Samson et al.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2020)

Add to Collection

Review Endocrinology & Metabolism

Multidisciplinary management of acromegaly: A consensus

Andrea Giustina et al.

REVIEWS IN ENDOCRINE & METABOLIC DISORDERS (2020)

Add to Collection

Review Endocrinology & Metabolism

Systemic Complications of Acromegaly and the Impact of the Current Treatment Landscape: An Update

Monica R. Gadelha et al.

ENDOCRINE REVIEWS (2019)

Add to Collection

Article Medicine, General & Internal

Acromegaly

Annamaria Colao et al.

NATURE REVIEWS DISEASE PRIMERS (2019)

Add to Collection

Review Endocrinology & Metabolism

The burden of disease for pituitary patients

Nienke R. Biermasz

BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM (2019)

Add to Collection

Article Medicine, General & Internal

Patient-centered assessment on disease burden, quality of life, and treatment satisfaction associated with acromegaly

Shuqian Liu et al.

JOURNAL OF INVESTIGATIVE MEDICINE (2018)

Add to Collection

Article Endocrinology & Metabolism

A Consensus Statement on acromegaly therapeutic outcomes

Shlomo Melmed et al.

NATURE REVIEWS ENDOCRINOLOGY (2018)

Add to Collection

Article Endocrinology & Metabolism

High-Dose and High-Frequency Lanreotide Autogel in Acromegaly: A Randomized, Multicenter Study

Andrea Giustina et al.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2017)

Add to Collection

Article Endocrinology & Metabolism

Patient-reported outcomes of parenteral somatostatin analogue injections in 195 patients with acromegaly

Christian J. Strasburger et al.

EUROPEAN JOURNAL OF ENDOCRINOLOGY (2016)

Add to Collection

Review Endocrinology & Metabolism

Current and Emerging Aspects of Diabetes Mellitus in Acromegaly

Stefano Frara et al.

TRENDS IN ENDOCRINOLOGY AND METABOLISM (2016)

Add to Collection

Article Endocrinology & Metabolism

Safety and Efficacy of Oral Octreotide in Acromegaly: Results of a Multicenter Phase III Trial

Shlomo Melmed et al.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2015)

Add to Collection

Article Endocrinology & Metabolism

Acromegaly Clinical Trial Methodology Impact on Reported Biochemical Efficacy Rates of Somatostatin Receptor Ligand Treatments: A Meta-Analysis

John D. Carmichael et al.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2014)

Add to Collection

Review Endocrinology & Metabolism

EXPERT CONSENSUS DOCUMENT A consensus on the medical treatment of acromegaly

Andrea Giustina et al.

NATURE REVIEWS ENDOCRINOLOGY (2014)

Add to Collection

Article Endocrinology & Metabolism

Effects of high-dose octreotide LAR on glucose metabolism in patients with acromegaly inadequately controlled by conventional somatostatin analog therapy

Gherardo Mazziotti et al.

EUROPEAN JOURNAL OF ENDOCRINOLOGY (2011)

Add to Collection

Article Endocrinology & Metabolism

High-dose intramuscular octreotide in patients with acromegaly inadequately controlled on conventional somatostatin analogue therapy: a randomised controlled trial

Andrea Giustina et al.

EUROPEAN JOURNAL OF ENDOCRINOLOGY (2009)

Add to Collection

Review Endocrinology & Metabolism

Effects of Somatostatin Analogs on Glucose Homeostasis: A Metaanalysis of Acromegaly Studies

Gherardo Mazziotti et al.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2009)

Add to Collection

Article Health Care Sciences & Services

Open label extension studies and patient selection biases

Karla Hemming et al.

JOURNAL OF EVALUATION IN CLINICAL PRACTICE (2008)

Add to Collection

Article Endocrinology & Metabolism

Primary treatment of acromegaly with octreotide LAR: a long-term (up to nine years) prospective study of its efficacy in the control of disease activity and tumor shrinkage

R Cozzi et al.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)

Add to Collection

© Peeref 2019-2024. All rights reserved.